BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31020001)

  • 1. Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.
    Braggin JE; Bucks SA; Course MM; Smith CL; Sopher B; Osnis L; Shuey KD; Domoto-Reilly K; Caso C; Kinoshita C; Scherpelz KP; Cross C; Grabowski T; Nik SHM; Newman M; Garden GA; Leverenz JB; Tsuang D; Latimer C; Gonzalez-Cuyar LF; Keene CD; Morrison RS; Rhoads K; Wijsman EM; Dorschner MO; Lardelli M; Young JE; Valdmanis PN; Bird TD; Jayadev S
    Ann Clin Transl Neurol; 2019 Apr; 6(4):762-777. PubMed ID: 31020001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Course MM; Gudsnuk K; Keene CD; Bird TD; Jayadev S; Valdmanis PN
    Brain; 2023 Feb; 146(2):507-518. PubMed ID: 35949106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Giau VV; Bagyinszky E; Youn YC; An SSA; Kim S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization.
    Zhou R; Yang G; Shi Y
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12731-12736. PubMed ID: 29078389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
    Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Hsu S; Pimenova AA; Hayes K; Villa JA; Rosene MJ; Jere M; Goate AM; Karch CM
    Neurobiol Dis; 2020 Jun; 139():104817. PubMed ID: 32087291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease.
    Guven G; Samanci B; Gulec C; Hanagasi H; Gurvit H; Gokalp EE; Tepgec F; Guler S; Uyguner O; Bilgic B
    Neurol Sci; 2021 Jun; 42(6):2497-2504. PubMed ID: 33855622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of γ-secretase activity.
    Moussavi Nik SH; Newman M; Wilson L; Ebrahimie E; Wells S; Musgrave I; Verdile G; Martins RN; Lardelli M
    Hum Mol Genet; 2015 Jul; 24(13):3662-78. PubMed ID: 25814654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis.
    Islam S; Sun Y; Gao Y; Nakamura T; Noorani AA; Li T; Wong PC; Kimura N; Matsubara E; Kasuga K; Ikeuchi T; Tomita T; Zou K; Michikawa M
    J Neurosci; 2022 Feb; 42(8):1574-1586. PubMed ID: 34987110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double Mutations in a Patient with Early-Onset Alzheimer's Disease in Korea: An
    Bae H; Shim KH; Yoo J; Yang YS; An SSA; Kang MJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.
    Shi Z; Wang Y; Liu S; Liu M; Liu S; Zhou Y; Wang J; Cai L; Huo YR; Gao S; Ji Y
    Dement Geriatr Cogn Disord; 2015; 39(1-2):32-40. PubMed ID: 25323700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Possible Pathogenic PSEN2 Gly56Ser Mutation in a Korean Patient with Early-Onset Alzheimer's Disease.
    Shim KH; Kang MJ; Bae H; Kim D; Park J; An SA; Jeong DE
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration in
    Montenegro P; Chen P; Kang J; Lee SH; Leone S; Shen J
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2306714120. PubMed ID: 37816062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene mutations in a Han Chinese Alzheimer's disease cohort.
    Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
    Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.
    Lleó A; Blesa R; Queralt R; Ezquerra M; Molinuevo JL; Peña-Casanova J; Rojo A; Oliva R
    Arch Neurol; 2002 Nov; 59(11):1759-63. PubMed ID: 12433263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.